Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,655
Medtronic Cardiac Surgery PMCF Registry
for
Valve Disease, Heart
Location: Durham NC, Falls Church VA, Pittsburgh PA, Marietta GA,
Sponsor: Medtronic Cardiac Surgery
Sex: All
Age: 0+
Code: NCT04073420
Recruiting
Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia
for
Primary Insomnia
Location: Durham NC
Sponsor: Helicor
Sex: All
Age: 18 - 55
Code: NCT00415714
Recruiting
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
for
Clear Cell Renal Cell Carcinoma
Location: Durham NC, Charlotte NC, Atlanta GA, Columbus OH,
Sponsor: Xencor, Inc.
Sex: All
Age: 18+
Code: NCT05433142
Phase 1, Recruiting
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
for
Oral Mucositis
Location: Durham NC, Philadelphia PA, New York NY, Gainesville FL,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT00901732
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Durham NC, Fairfax VA, New York NY, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
for
Advanced Solid Tumor Cancer
Location: Durham NC, Baltimore MD, Pittsburgh PA, Philadelphia PA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18+
Code: NCT04777994
Phase 1, Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Durham NC, Huntersville NC, Fairfax VA, Louisville KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer
for
Breast Cancer
Location: Durham NC
Sponsor: National Center for Research Resources (NCRR)
Sex: Female
Age: 18 - 70+
Code: NCT00006433
Phase 2, Recruiting
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for
Lung Transplant Rejection
Location: Durham NC, Falls Church VA, Baltimore MD,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06082037
Phase 3, Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Durham NC, Greenville NC, Winston-Salem NC, Richmond VA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase 3, Recruiting
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy
Location: Wake Forest NC, Ladson SC, Chevy Chase MD, Augusta GA,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07215234
Phase 1, Phase 2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
for
Heart Failure
Location: Morrisville NC, Greenville NC, Charlotte NC, Salem VA,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06024746
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype